IP Verse

Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 Antagonists

Patent No. EP3487881 (titled "Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 Antagonists") was filed by Novartis on Jul 18, 2017. The application was issued on Aug 21, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BRAND MURRAY FULLERMay 21, 2025BRAND MURRAY FULLER
DEHMEL & BETTENHAUSEN PATENTANWALTE PARTMBBMay 21, 2025RUCKERL
GRAF VON STOSCH PATENTANWALTSGESELLSCHAFTMay 21, 2025LEPTHIEN
HAMPTON KNOWLESMay 21, 2025D YOUNG
J A KEMPMay 21, 2025J A KEMP
MAIWALDMay 21, 2025MAIWALD
NEUEFEINDMay 20, 2025MAIWALD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3487881

NOVARTIS
Application Number
EP17754796A
Filing Date
Jul 18, 2017
Status
Granted And Under Opposition
Jul 19, 2024
Publication Date
Aug 21, 2024
External Links
Slate, Register , Google Patents